Production & Manufacturing
Fine & Speciality Chemicals

Highly Active Pharmaceutical Ingredients

Published 27 May 2014 | By Sanofi CEPiA

A key activity is the manufacturing of highly active pharmaceutical ingredients (HAP) and cytotoxic compounds. This activity stems from Sanofi’s expertise gained through the manufacturing of taxanes (Docetaxel, Taxotere® and Cabazitaxel, Jevtana®) and in the development of other drugs for oncology. CEPiA is glad to present to customers its dedicated equipment and facilities for highly active products manufacturing.

Available Downloads

Highly Active Pharmaceutical Ingredients